Table 3.
Discrimination of varying Gleason grade categorizations
| RP biopsy Gleason grade | Post-RP Gleason grade | RT Gleason grade | ||||
|---|---|---|---|---|---|---|
| Univariate | Multivariable | Univariate | Multivariable | Univariate | Multivariable | |
| ≤6 vs 7 vs ≥8 | 0.760 | 0.805 | 0.744 | 0.83 | 0.662 | 0.729 |
| ≤6 vs 3 + 4 vs 4 + 3 vs ≥8 | 0.781 | 0.811 | 0.791 | 0.842 | 0.684 | 0.736 |
| ≤6 vs 7 vs 8 vs ≥9 | 0.762 | 0.806 | 0.747 | 0.831 | 0.666 | 0.729 |
| ≤6 vs 3 + 4 vs 4 + 3 vs 8 vs ≥9 | 0.783 | 0.813 | 0.793 | 0.842 | 0.687 | 0.737 |
RP = radical prostatectomy; RT = radiation therapy.
Multivariable biopsy Gleason Cox model includes preoperative prostate-specific antigen (PSA) and clinical stage (T1 vs T2 vs T3/4), and post-RP Cox model includes preoperative PSA, surgical margin status, and pathology stage (pT2 vs pT3a vs pT3b vs pT4). The C-index has been corrected for optimism using 10-fold cross-validation.